Search

everythinglearnresearchcommunity

for

Search:↓

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

CD2 might be a new treatment target for patchy alopecia areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A woman with lupus had rare severe symptoms but improved with treatment.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Certain diseases like AIDS and lupus can make African hair become silky.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

A genetic marker linked to a type of hair loss was found in most patients studied.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.